Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(3.04)
# 2,732
Out of 4,662 analysts
24
Total ratings
52.9%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Maintained: Hold | $5 | $6.25 | -20.00% | 2 | Aug 11, 2026 | |
| ILMN Illumina | Downgraded: Hold | $185 | $205.00 | -9.76% | 1 | Aug 5, 2026 | |
| VMD Viemed Healthcare | Downgraded: Hold | $11 | $8.94 | +23.04% | 1 | Aug 5, 2026 | |
| SMTI Sanara MedTech | Downgraded: Hold | $35 | $34.28 | +2.10% | 2 | Aug 3, 2026 | |
| JNJ Johnson & Johnson | Upgraded: Buy | $280 | $273.41 | +2.41% | 1 | Jul 16, 2026 | |
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $3.17 | +183.91% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $10.28 | +162.65% | 1 | Jul 2, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.5328 | +556.91% | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $9.60 | +4.17% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $442.36 | -15.23% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $245 | $221.56 | +10.58% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $5.68 | +111.27% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $16.07 | -0.44% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $87.40 | +32.72% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $4.20 | +376.19% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.19 | +173.97% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $19.73 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $5.79 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $13.50 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $40.87 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $3.40 | n/a | 1 | Mar 18, 2025 |
Sionna Therapeutics
Aug 11, 2026
Maintained: Hold
Price Target: $5
Current: $6.25
Upside: -20.00%
Illumina
Aug 5, 2026
Downgraded: Hold
Price Target: $185
Current: $205.00
Upside: -9.76%
Viemed Healthcare
Aug 5, 2026
Downgraded: Hold
Price Target: $11
Current: $8.94
Upside: +23.04%
Sanara MedTech
Aug 3, 2026
Downgraded: Hold
Price Target: $35
Current: $34.28
Upside: +2.10%
Johnson & Johnson
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $273.41
Upside: +2.41%
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.17
Upside: +183.91%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $10.28
Upside: +162.65%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.5328
Upside: +556.91%
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $9.60
Upside: +4.17%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $442.36
Upside: -15.23%
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $221.56
Upside: +10.58%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $5.68
Upside: +111.27%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $16.07
Upside: -0.44%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $87.40
Upside: +32.72%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $4.20
Upside: +376.19%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $2.19
Upside: +173.97%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $19.73
Upside: n/a
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $5.79
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $13.50
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $40.87
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $3.40
Upside: n/a